EFFICACY AND SAFETY OF PIDOTIMOD IN THE TREATMENT OF RECURRENT RESPIRATORY INFECTIONS IN CHILDREN

EFFICACY AND SAFETY OF PIDOTIMOD IN THE TREATMENT OF RECURRENT RESPIRATORY INFECTIONS IN CHILDREN

Show other versions (1)

The immunomodulating activity of pidotimod (imunorix) was evaluated in a doublebblind, placebobcontrolled, randomized, multicentre trial, on 120 pediatric patients affected by recurrent respiratory infections. Antibiotic therapy and time of hospitalization were shorter in the patients taking pidotim...

Full description

Bibliographic Details
Main Authors: G. Caramia, E. Clemente, R. Solli, V. Mei, R. Cera, V. Carnelli, V. Venturoli, A. Corsini
Format: Article
Language:English
Published: "Paediatrician" Publishers LLC 2008-04-01
Series:Вопросы современной педиатрии
Subjects:
children
pidotimod
recurrent respiratory infections
management
Online Access:https://vsp.spr-journal.ru/jour/article/view/1371

Internet

https://vsp.spr-journal.ru/jour/article/view/1371

Similar Items